Roche Holding AG (RHHBY)
32.18
-0.46
(-1.41%)
USD |
OTCM |
Mar 18, 16:00
Roche Price: 32.18 for March 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 18, 2024 | 32.39 | 32.45 | 32.15 | 32.18 | 1.428M |
Mar 15, 2024 | 32.85 | 32.93 | 32.59 | 32.64 | 735015.0 |
Mar 14, 2024 | 33.00 | 33.09 | 32.66 | 32.89 | 4.438M |
Mar 13, 2024 | 34.69 | 34.83 | 34.07 | 34.22 | 1.757M |
Mar 12, 2024 | 34.65 | 35.21 | 34.61 | 35.15 | 1.189M |
Mar 11, 2024 | 34.26 | 34.67 | 34.22 | 34.61 | 1.459M |
Mar 08, 2024 | 33.86 | 33.96 | 33.77 | 33.90 | 802508.0 |
Mar 07, 2024 | 33.82 | 33.82 | 33.62 | 33.77 | 1.083M |
Mar 06, 2024 | 33.31 | 33.50 | 33.27 | 33.47 | 1.379M |
Mar 05, 2024 | 33.21 | 33.32 | 33.11 | 33.15 | 768642.0 |
Mar 04, 2024 | 32.81 | 33.00 | 32.80 | 32.88 | 979795.0 |
Mar 01, 2024 | 33.08 | 33.08 | 32.75 | 33.08 | 1.326M |
Feb 29, 2024 | 33.00 | 33.07 | 32.68 | 32.73 | 1.693M |
Feb 28, 2024 | 32.85 | 32.98 | 32.75 | 32.93 | 1.726M |
Feb 27, 2024 | 32.90 | 33.05 | 32.85 | 33.03 | 2.357M |
Feb 26, 2024 | 32.94 | 32.95 | 32.46 | 32.52 | 1.679M |
Feb 23, 2024 | 32.64 | 33.03 | 32.62 | 32.96 | 998036.0 |
Feb 22, 2024 | 32.42 | 32.54 | 32.35 | 32.49 | 1.414M |
Feb 21, 2024 | 32.73 | 32.98 | 32.65 | 32.91 | 2.631M |
Feb 20, 2024 | 33.00 | 33.04 | 32.67 | 32.74 | 3.270M |
Feb 16, 2024 | 32.20 | 32.37 | 32.11 | 32.28 | 1.611M |
Feb 15, 2024 | 32.20 | 32.40 | 32.04 | 32.10 | 2.319M |
Feb 14, 2024 | 32.04 | 32.09 | 31.91 | 32.02 | 2.154M |
Feb 13, 2024 | 32.27 | 32.36 | 32.10 | 32.13 | 1.378M |
Feb 12, 2024 | 32.30 | 32.63 | 32.29 | 32.60 | 2.195M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
31.99
Minimum
May 13 2019
53.44
Maximum
Apr 08 2022
40.90
Average
40.98
Median
Nov 24 2020
Price Benchmarks
Novartis AG | 95.92 |
Pfizer Inc | 27.72 |
Gilead Sciences Inc | 73.26 |
Eli Lilly and Co | 762.66 |
CRISPR Therapeutics AG | 71.46 |
Price Related Metrics
PE Ratio | 16.08 |
PS Ratio | 3.057 |
Price to Book Value | 5.881 |
Price to Free Cash Flow | 16.14 |
Earnings Yield | 6.22% |
Market Cap | 205.24B |
Operating PE Ratio | 12.02 |
Normalized PE Ratio | 15.90 |